0
PathHunter® Cell-Based Protease Assays
Frost & Sullivan selected DiscoveRx Corporation as the recipient of the 2006 Frost & Sullivan Award for Technology Innovation for its development of the PathHunter®, an innovative protein trafficking platform. PathHunter cell-based protease assays provides a novel, homogeneous approach for detection of secreted protein utilizing the prorietary Enzyme fragment complementation (EFC) technolgoy. In the identification of inhibitors to proteases, pharmarceutical companies consider specificity as a key assay feature. First generation MMP inhibitors failed in late stages of drug development because of promiscuity of proteases that resulted in a lot of side effects. PathHunter cell based protease assays thus provide specificity and cellular context offering a simple solution to the complex world of proteases.
Product Features
Cell-based functional assay
Ideal for high throughput screening
Chemiluminescent assay reduces false positives
Simple, two addition protocol
For instrument compatibility, please click here.
Click on figure to enlarge
Click on figure to enlarge
Available Literature
Click here to view what we have available!
How does the assay work?
Click here to view assay principle of PCSK9
Click here to view assay principle of ADAM10
Copyright ©2009, DiscoveRx Corporation. TERMS AND CONDITIONS